WinstonWınston
Medical Supply International USA logo

Medical Supply International USA

MSIU
51
Medical - Devices · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$20,405
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.

Medical Supply International USA, Inc. (MSIU) is a small healthcare company that sells medical devices and supplies. Its products are used in clinical and patient care settings, with hospitals, clinics, and healthcare providers as its main customers. The company operates in the broader medical devices industry, which supplies tools and equipment that doctors and nurses use to treat patients.

MSIU earns revenue by selling medical products directly to healthcare buyers, and its 62% gross margin suggests it focuses on higher-value or specialized items rather than basic commodity supplies. The company appears to operate primarily in the United States, and with a market cap near zero it is a very small player in a large, competitive industry. Its reported return on invested capital of over 100% is unusually high for a company this size, which could reflect either a lean business model or limited publicly available financial data — investors should verify the numbers carefully before drawing conclusions.

Winston Score History

Share count broadly stable

0.0% over 12y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 25.5M (2005) → 25.5M (2017)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
62.4%
no trend
Premium pricing power — 62.4% gross margin
Operating Margin
15.6%
no trend
Healthy — 15.6% operating margin
ROCE
104.3%
no trend
Exceptional — 104.3% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-22.6%
no trend
Shrinking sales (-22.6% YoY)
EPS YoY
+7650.0%
no trend
Earnings growing fast (7650.0% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
-45%
no trend
Weak — only -45% of profit becomes cash
FCF Margin
-6.9%
no trend
Burning cash (-6.9%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
1.18
no trend
Elevated debt (1.18)
Interest Cover
10.11x
no trend
Comfortably covers interest (10.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.1x
no trend
Attractive valuation — P/E 0.1

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial